Skip to main content

ScienceDex / Researcher record

Qyang, Yibing

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #5,713
  • R01 Holder
  • Long-Funded

NIH Funding · FY2023

$1.5M
Full award amounts, FY2023
4
Records listing this PI
#5,713
By linked amount among FY2023 PIs
2010
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2010$95,4991#40,595
2011$98,3641#37,753
2012$98,3641#37,600
2013$494,6342#15,120
2014$506,2892#15,159
2015$410,0061#18,458
2016$835,0002#8,623
2017$835,0002#8,688
2018$418,7501#21,139
2019$418,7501#22,644
2021$1,144,9483#7,834
2022$1,576,6705#5,193
2023$1,513,2494#5,713

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20101 record
  2. FY20111 record
  3. FY20121 record
  4. FY20132 records
  5. FY20142 records
  6. FY20151 record
  7. FY20162 records
  8. FY20172 records
  9. FY20181 record
  10. FY20191 record
  11. FY20213 records
  12. FY20225 records
  13. FY2023 · selected4 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Qyang, Yibing. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2027 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2010 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2023 award categories

  • Internal Medicine

FY2023 award records by amount

NIH award records listing Qyang, Yibing as a PI. Multi-PI records show the full award amount for context.

  • 5R01HL150352-04R01Contact PI
    Readily Available Stem Cell-Based Vascular Grafts for Emergent Surgical Care
    Yale University · Internal Medicine (NIH department code)
    $664.3K
    award amount
  • 5R01HL164783-02R01Contact PI
    Modulation of heart function by Muscle LIM protein-mediated mechanotransduction
    Yale University · Internal Medicine (NIH department code)
    $418.8K
    award amount
  • 5R01HL155411-03R01Contact PI
    Development of HLA engineered universal vascular grafts from human iPSCs
    Yale University · Internal Medicine (NIH department code)
    $418.8K
    award amount
  • 3R01HL150352-04S1R01Contact PI
    Readily Available Stem Cell-Based Vascular Grafts for Emergent Surgical Care
    Yale University · Internal Medicine (NIH department code)
    $11.4K
    award amount

Award organization

Organizations that administered FY2023 awards listing Qyang, Yibing as a PI.

FY2023 award administered by Yale University (CT).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2010
    First NIH Award
    Yale University
  2. 2013
    $500K Cumulative Funding
  3. 2014
    $1M Cumulative Funding
  4. 2014
    R01 Grant Holder
  5. 2016
    $2M Cumulative Funding
  6. 2016
    Entered Top 50% Nationally
    Ranked #8623
  7. 2021
    $5M Cumulative Funding